ATRITECH

Atritech is a private company located in Minneapolis, Minnesota. The company was founded in 2000 and has developed proprietary technology focused on replacing long term anticoagulation therapy for patients with non-valvular atrial fibrillation at risk of stroke. The first implants of the WATCHMANÂ® Left Atrial Appendage Closure Technology were performed in Germany in August of 2002 and in the United States in October of 2003. Since then the company has conducted a large randomized clinical... trial comparing the WATCHMANÂ® Left Atrial Appendage Closure Technology to long term Warfarin therapy in patients with non-valvular atrial fibrillation at risk of stroke. The WATCHMANÂ® Device is CE Marked and available in many markets outside the United States. The WATCHMANÂ® Device is currently available For Investigational Use Only in the United States.

#SimilarOrganizations #Financial #Website #More

ATRITECH

Social Links:

Industry:

Clinical Trials Health Care Medical Device Therapeutics

Founded:

2000-01-01

Address:

Plymouth, Minnesota, United States

Country:

United States

Website Url:

http://www.atritech.net

Total Employee:

10001+

Status:

Active

Contact:

763.258.0250

Email Addresses:

[email protected]

Total Funding:

83.6 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Apache Amazon